Poseltinib 5 mg | ≥98% Cayman Chemical An irreversible inhibitor of BTK More Information Supplier Page × Poseltinib
Poseltinib 25 mg | ≥98% Cayman Chemical An irreversible inhibitor of BTK More Information Supplier Page × Poseltinib
Poseltinib 10 mg | ≥98% Cayman Chemical An irreversible inhibitor of BTK More Information Supplier Page × Poseltinib
Poseltinib 1 mg | ≥98% Cayman Chemical An irreversible inhibitor of BTK More Information Supplier Page × Poseltinib
Perfluoroheptanesulfonic Acid 5 mg | ≥95% Cayman Chemical A perfluoroalkyl substance More Information Supplier Page × Perfluoroheptanesulfonic Acid
Interleukin-8 (54-72) (human) (scrambled) (trifluoroacetate 500 µg | ≥98% Cayman Chemical A negative control for IL-8 (54-72) (human) More Information Supplier Page × Interleukin-8 (54-72) (human) (scrambled) (trifluoroacetate
TLQP 21 (trifluoroacetate salt) 5 mg | ≥95% Cayman Chemical A neuropeptide and fragment of VGF More Information Supplier Page × TLQP 21 (trifluoroacetate salt)
TLQP 21 (trifluoroacetate salt) 25 mg | ≥95% Cayman Chemical A neuropeptide and fragment of VGF More Information Supplier Page × TLQP 21 (trifluoroacetate salt)
TLQP 21 (trifluoroacetate salt) 10 mg | ≥95% Cayman Chemical A neuropeptide and fragment of VGF More Information Supplier Page × TLQP 21 (trifluoroacetate salt)
TLQP 21 (trifluoroacetate salt) 1 mg | ≥95% Cayman Chemical A neuropeptide and fragment of VGF More Information Supplier Page × TLQP 21 (trifluoroacetate salt)